Status
Conditions
About
An increased number of patients with heparin-induced skin lesions is reported in the literature. Heparin-induced skin lesions may result from either occlusion of cutaneous vessels in patients suffering from autoimmune HIT or from a type IV allergic reaction (delayed type hypersensitivity (DTH) response). However, the incidence and nature of heparin-induced skin lesions has not been determined in a prospective investigation.
To address this open issue is the goal of this ongoing, so far monocenter, clinical investigation.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
500 participants in 1 patient group
Loading...
Central trial contact
Ralf J Ludwig, MD; Wolf-Henning Boehncke, Professor
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal